RCKT

Rocket Pharmaceuticals INC

-$348.2M

Net Activity

Institutions Holding

2

Popularity Rank

#5210

Avg Weight

0.00%

Total Value

$294.2K

Ownership Trend

2 institutions currently hold RCKT, with 0 net buyers and 3 net sellers this quarter.

Institutional Moves

Institutional Moves (Q2 2026)

Significantly Decreased

Based on recent trading activity

Net Selling Institutions

3

Net Buying Institutions

0

Key Holders

Key Holders

Top 5 by Value

AA
Assenagon Asset Management S.A.
$290.1K
GI
GAMMA Investing LLC
$4.1K

Top 5 by Conviction

AA
Assenagon Asset Management S.A.
0.00%
GI
GAMMA Investing LLC
0.00%
View all 2 holding institutions

Quarterly Activity

Recent Activity

+$0.0

Total Buy Value

$461.9K

Total Sell Value

New buy0
Trim2
Add0
Sold out1

0

Net Buyers

3

Net Sellers

Insider Trading (Form 4)

Form 144 Pre-Sale Notices

1

Filings (90d)

$41K

Total Est. Value

11K shares

Planned Shares

Last Filed 2026-07-07
FilerFiling DateEst. Value
Malik Fady Ibraham2026-07-07$41K

Form 144 is a planned sale notice, not an executed transaction. Form 144 Tracker。

Beneficial Ownership (13D/13G)

No Schedule 13D/13G filings for this ticker

Material Events (8-K)

1

Filings (14d)

Data as of 2026-06-30
2026-06-30

Rocket Pharmaceuticals announced the resignation of John Militello as VP of Finance, Senior Controller, Treasurer, and Principal Accounting Officer, effective July 7, 2026, to pursue other opportunities. On June 30, the company appointed Joseph Manhede, currently Associate Vice President, Corporate Controller, as the new Principal Accounting Officer, effective July 8, 2026. Manhede, 48, is a CPA with prior experience at Deloitte, Outlook Therapeutics, and other pharmaceutical companies. No new compensatory arrangements were made for this role.

View Full Filing (SEC EDGAR)

View all Form 8-K filings

FAQ

Who are the top institutional investors holding ROCKET PHARMACEUTICALS INC (RCKT)?
Major stakeholders currently include Assenagon Asset Management S.A. ($290.1K), GAMMA Investing LLC ($4.1K). Based on the latest 13F filings, there are a total of 2 tracked investment funds and institutions maintaining positions in RCKT.
What is the overall institutional sentiment toward RCKT recently?
Institutional sentiment appears Bearish (Net Selling). During the most recent reporting quarter, the stock experienced a net outflow of $348.2M, driven by 0 managers accumulating shares while 3 reduced their exposure.
Which institutions have been selling or reducing their RCKT positions?
In the latest period, 2 funds trimmed their holdings, and 1 managers completely exited their positions. The aggregate reported sell value was $461.9K.
Are there any notable investors adding RCKT to their portfolios?
No tracked institutions opened new positions or added to their existing holdings in RCKT during the last reporting period.

Related Stocks

Trending Institutional Adds

The most-added stocks by 13F institutions this quarter

MSFT

Microsoft CORP

Institutions Holding

601

Total reported value

$20.1B

310 13F institutions increased their position this quarter

View detail
NVDA

Nvidia CORP

Institutions Holding

563

Total reported value

$25.2B

299 13F institutions increased their position this quarter

View detail
VUG

Vanguard Growth ETF

Institutions Holding

302

Total reported value

$4.3B

269 13F institutions increased their position this quarter

View detail